The IFM 2018-04 approach to high-risk multiple myeloma. Visual illustration of the IFM 2018-04 trial, including induction with D-KRd and 2 ASCTs. Professional illustration by Somersault18:24.

The IFM 2018-04 approach to high-risk multiple myeloma. Visual illustration of the IFM 2018-04 trial, including induction with D-KRd and 2 ASCTs. Professional illustration by Somersault18:24.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal